Clinical Trial Update: Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2, single-arm clinical trial evaluating the combination of everolimus and letrozole for platinum-resistant or persistent ovarian and endometrial cancers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• Afinitor (everolimus)
• FEMARA (letrozole)

Snippet

Sponsor: Sinai Hospital of Baltimore | Conditions: Ovarian Cancer, Endometrial Cancer | Phase 2 | Status: UNKNOWN